Thanks for the info, Kavitha.
Basically, you are concentrating the sample out of the sample matrix so that you can get most of the sample into the diluent and minimize volatile excipients.
However, the problem is: Both Polycarbophil & Polaxamer are still being extracted into the diluent because they are equally soluble in all diluents tested for the sample.
And these excipients are showing up at the peak of interest in the placebo.
Let us try this instead: (we will avoid the heating procedure and adapt a direct method)
1. Assuming that your workable or hplc injectable concentration is 10 ug/ml or 10 ppm.
2. Use a "To contain pipet" (TC pipet is different from TD) aliquot 1 ml of the sample (whole sample solution containing the excipients) into a 100 ml class A volumetric flask. I assume you know how to use the "TC" pipet. Add the diluent, make up to volume and mix well. Now, you essentially have a 10 ug/ml nominal concentration sample solution.
If aliquoting using a "1mL TC pipet" is difficult since your sample is highly viscous, use a larger 4mL or 5 mL TC pipet and prepare accordingly (say 5 mL in 500 mL).
3. Now you a 10 ppm solution of the sample (including all potential excipients) in the diluent and all being solubilized (Make sure they are all soluble or adjust dilution scheme accordingly).
4. Using a 0.45 uM filter, filter the diluent into the HPLC injection vial and shoot at your HPLC conditions.
5. This might or might not help, and still you see the excipients at the peak of interest.
Now let us modify the HPLC conditions (hopefully you are not following a validated method, if you are - please let me know):
1. Increase %B or ACN concentration plus or minus 5% in your mobile phase and see if this moves the excipient peaks away from the BKC.
If not try, plus or minus 10%.
2. If step 1. doesn't work - use either a Cyano CN column or Phenyl column and perform the separation.
Let me know the results.